Related Funds
Fund Name | Location |
Advertising, Art & Ideas | Switzerland, Zürich, Zurich |
AIRmaker | Central, Central Region, Singapore |
Bennesse Holdings | Japan, Okayama, Okayama Prefecture |
Business angels | - |
Cedarville Investments | Arkansas, Arkansas City, United States |
Central Exchange | China, Hong Kong, Hong Kong Island |
Dajin Heavy Industries | China, Fuxin, Liaoning |
Empiricus Capital | New York, New York, United States |
ERGO Group | Düsseldorf, Germany, Nordrhein-Westfalen |
Fox Networks Group | California, Los Angeles, United States |
Hualing Guanhong Gongyinglian Guanli | China, Guangdong, Shenzhen |
Huanxin Touzi | China, Guangdong Province, Yuexiu District |
Hypur Ventures | Arizona, Scottsdale, United States |
Orn Group | Australia, New South Wales, Norway |
PKO BP | Mazowieckie, Poland, Warszawa |
RA Capital Advisors LLC | California, San Diego, United States |
The Libra Foundation | California, San Francisco, United States |
Travel Capitalist Ventures (USA, S Africa, Mideast, India) | California, Irvine, United States |
Vidal Healthcare | Bangalore, India, Karnataka |
WRD Capital | - |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Kula Bio | $50M | 03 Jan 2022 | Massachusetts, United States | ||
JOINN Biologics | $150M | 01 Aug 2021 | Richmond, California, United States | ||
$20M | 19 Jul 2019 | Beijing | |||
Kyulux | $31M | 27 May 2019 | Fukuoka, Fukuoka Prefecture, Japan | ||
XtalPi | $46M | 25 Oct 2018 | United States, Cambridge | ||
OncoResponse | $40M | 11 Sep 2018 | Seattle, Washington, United States | ||
Cue | $45M | 10 Jul 2018 | San Diego, California, United States | ||
3NT Medical | $15M | 08 May 2018 | North District | ||
YouWorld | 19 Feb 2018 | Pasadena, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Kula Bio | $50M | 03 Jan 2022 | Massachusetts, United States | ||
JOINN Biologics | $150M | 01 Aug 2021 | Richmond, California, United States | ||
$20M | 19 Jul 2019 | Beijing | |||
Kyulux | $31M | 27 May 2019 | Fukuoka, Fukuoka Prefecture, Japan | ||
XtalPi | $46M | 25 Oct 2018 | United States, Cambridge | ||
OncoResponse | $40M | 11 Sep 2018 | Seattle, Washington, United States | ||
Cue | $45M | 10 Jul 2018 | San Diego, California, United States | ||
3NT Medical | $15M | 08 May 2018 | North District | ||
YouWorld | 19 Feb 2018 | Pasadena, California, United States |